Ask My Investor AI
Public company · NYSEPublished company research
J

Legal name, ticker, exchange, reporting currency and CIK are verified from the FY2025 Form 10-K.

Jacobs Solutions Inc.

Jacobs combines a dedicated PFAS practice with large-scale municipal treatment design and testing references. Q2 FY2026 issuer results reported $3.695 billion of gross revenue and $27.0 billion of backlog. No issuer source isolates PFAS revenue, backlog, orders or margins, so the direct capability is not yet a financially material investment thesis.

Ask follow-up research
Reviewed company research · researched 2026-07-29 · not an individual investment recommendation
Listing
public
Ticker
J
Exchange
NYSE
HQ
United States
Currency
USD
SEC CIK
0000052988
Investment case

How this company captures the theme economics

Competitive position

Official Jacobs sources describe PFAS work across investigation, risk assessment, treatment selection, design, implementation and long-term management. The company designed Woodbury's 32-million-gallon-per-day PFAS plant and supported Orange County Water District treatment testing, demonstrating real project execution rather than marketing-only exposure.

Scarce assets

PFAS specialists, PFluorensics data tools, treatability-testing capability and experience designing large municipal PFAS treatment systems.

Products, segments, and customers

Jacobs provides consulting, engineering, design and program-management services. Its PFAS practice covers industrial, water, infrastructure, remediation and compliance work, but PFAS is not a separately reported segment.

Theme capture

Jacobs can capture utility and industrial PFAS spending through assessment, testing, treatment selection, design and program management. Official sources verify named projects, but no PFAS-specific economics are disclosed.

Conditions

What must be true

  1. Named PFAS project capability must translate into a repeatable, measurable pipeline.
  2. PFAS work must become material within Jacobs' broader water and environmental portfolio.

Identifiable catalysts

  • New named PFAS treatment awards.
  • Issuer disclosure of PFAS-specific backlog, revenue or orders.
Theme materiality

2 mapped themes

Exposure statements are evidence-qualified. Materiality is only claimed where disclosure supports it.

PFAS assessment, treatment testing, engineering design and program management for municipal, industrial and infrastructure clients.

PFAS treatment, destruction and liability transfer

Direct project-evidenced capability is verified by Jacobs' PFAS practice, Woodbury treatment-plant design and Orange County Water District testing support. PFAS economics remain unquantified inside the consolidated business.

Evidence
Official Jacobs pages directly support practice scope and named projects. FY2025 and Q2 FY2026 reporting supports issuer scale but does not isolate PFAS revenue, backlog, orders or margins.
Materiality
not assessed — Official sources verify capability and named projects but do not disclose PFAS-specific economics; materiality fails closed as not assessed.
Water and infrastructure consulting and engineering provider.

Climate risk transferring into municipal finance

Jacobs has relevant public-infrastructure and water capabilities, but climate-municipal-credit exposure is not separately quantified.

Evidence
Official filing evidence supports consolidated scale only.
Materiality
not assessed — No issuer disclosure isolates theme-specific economics.
Financial evidence

Official SEC filing evidence

Reference period: Q2 FY2026.

  • Gross revenue$3.695 billion
    Q2 FY2026[2]
  • Adjusted net revenue$2.328 billion
    Q2 FY2026[2]
  • GAAP loss from continuing operations$43 million
    Q2 FY2026[2]
  • Adjusted EPS$1.75
    Q2 FY2026[2]
  • Backlog$27.0 billion, up 22% year over year
    Q2 FY2026[2]
  • Trailing-twelve-month book-to-bill1.4x
    Q2 FY2026[2]

Limitation: Current issuer reporting establishes consolidated scale and backlog. PFAS-specific economics and licensed current valuation remain unavailable.

Risks

Material risks and break conditions

Material risks

  • Public infrastructure funding and project timing can delay revenue.
  • Project execution and labor costs can pressure margins.
  • PFAS may remain immaterial inside the diversified portfolio.

Thesis-break conditions

  • Backlog and book-to-bill weaken materially for multiple quarters.
  • PFAS capability does not produce measurable commercial awards.
Investability conclusion

Where the evidence lands

NOT_READY: official evidence verifies identity, consolidated financial scale and direct PFAS project capability, but PFAS materiality and licensed current valuation remain unresolved. Human review is required before acceptance.

Next diligence

  1. Obtain official PFAS-specific orders, backlog, revenue and margins.
  2. Connect licensed valuation data and complete human review.
Source ledger

Identity and evidence sources

Identity was verified against official issuer, filing, exchange, or regulator sources where available.

  1. Jacobs Solutions Inc. FY2025 Form 10-KSEC EDGAR · primary · published 2025-11-20 · accessed 2026-07-29
  2. Jacobs Q2 FY2026 resultsJacobs Solutions Inc. · primary · published 2026-05-05 · accessed 2026-07-29
  3. PFAS SolutionsJacobs Solutions Inc. · primary · published n/a · accessed 2026-07-29
  4. Woodbury PFAS water treatment projectJacobs Solutions Inc. · primary · published n/a · accessed 2026-07-29
  5. Jacobs awarded PFAS treatment testing support services contract with Orange County Water DistrictJacobs Solutions Inc. · primary · published 2020-01-28 · accessed 2026-07-29